467 A real-world retrospective study of immunotherapy in NSCLC patients with KRAS mutation

Bibliographic Details
Main Authors: Hua Zhong, Huiping Qiang
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1827768422504595456
author Hua Zhong
Huiping Qiang
author_facet Hua Zhong
Huiping Qiang
author_sort Hua Zhong
collection DOAJ
first_indexed 2024-03-11T12:11:58Z
format Article
id doaj.art-9aef74bb611e44a990c74b1ef3f116c4
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-11T12:11:58Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-9aef74bb611e44a990c74b1ef3f116c42023-11-07T11:35:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0467467 A real-world retrospective study of immunotherapy in NSCLC patients with KRAS mutationHua Zhong0Huiping Qiang1Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaShanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
spellingShingle Hua Zhong
Huiping Qiang
467 A real-world retrospective study of immunotherapy in NSCLC patients with KRAS mutation
Journal for ImmunoTherapy of Cancer
title 467 A real-world retrospective study of immunotherapy in NSCLC patients with KRAS mutation
title_full 467 A real-world retrospective study of immunotherapy in NSCLC patients with KRAS mutation
title_fullStr 467 A real-world retrospective study of immunotherapy in NSCLC patients with KRAS mutation
title_full_unstemmed 467 A real-world retrospective study of immunotherapy in NSCLC patients with KRAS mutation
title_short 467 A real-world retrospective study of immunotherapy in NSCLC patients with KRAS mutation
title_sort 467 a real world retrospective study of immunotherapy in nsclc patients with kras mutation
work_keys_str_mv AT huazhong 467arealworldretrospectivestudyofimmunotherapyinnsclcpatientswithkrasmutation
AT huipingqiang 467arealworldretrospectivestudyofimmunotherapyinnsclcpatientswithkrasmutation